Liraglutide for patients with non-alcoholic steatohepatitis.

Liraglutide for patients with non-alcoholic steatohepatitis.

The Article by Matthew Armstrong and colleagues (Feb 13, p 679) reports different outcomes to those initially registered in the trial protocol.

Bibliografske podrobnosti
Main Authors:	Dale, A, Hartley, P, Heneghan, C
Format:	Journal article
Jezik:	English
Izdano:	Elsevier 2016

Podobne knjige/članki

Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
od: Armstrong, M, et al.
Izdano: (2013)

Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis.
od: Newsome, P, et al.
Izdano: (2012)

Non-alcoholic Steatohepatitis: An Overview
od: Allison Shifflet, et al.
Izdano: (2009-01-01)

Endocannabinoids and non-alcoholic steatohepatitis
od: Helmy Ahmed
Izdano: (2006-01-01)

Statins in Non-alcoholic Steatohepatitis
od: Jose D. Torres-Peña, et al.
Izdano: (2021-11-01)

Fructose and Non-Alcoholic Steatohepatitis
od: Elke Roeb, et al.
Izdano: (2021-02-01)

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
od: Singh Deepak, et al.
Izdano: (2010-07-01)

Role of alcohol metabolism in non-alcoholic steatohepatitis.
od: Susan S Baker, et al.
Izdano: (2010-03-01)

Therapeutic approaches for non-alcoholic steatohepatitis
od: Luc F. Van Gaal, et al.
Izdano: (2021-09-01)

Combined alcoholic and non-alcoholic steatohepatitisKey points
od: Line Carolle Ntandja Wandji, et al.
Izdano: (2020-06-01)

Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis
od: Ye. A. Fedos’ina, et al.
Izdano: (2010-06-01)

Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?
od: A.L. Chagas, et al.
Izdano: (2009-10-01)

Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?
od: A.L. Chagas, et al.

Clinical and histological features of non-Alcoholic steatohepatitis in Iranian patients
od: "Ebrahimi Daryani N, et al.
Izdano: (2003-03-01)

Clinical and histological features of non-Alcoholic steatohepatitis in Iranian patients
od: "Ebrahimi Daryani N, et al.
Izdano: (2003-05-01)

Clinical features of non-alcoholic steatohepatitis in patients with different glycemic status
od: A. A. Shipovskaya, et al.
Izdano: (2021-05-01)

Structure of anaemic conditions comorbid to alcoholic and non-alcoholic steatohepatitis
od: Oksana Khukhlina, et al.
Izdano: (2021-05-01)

Non-Alcoholic Steatohepatitis: Clinical and Translational Research
od: Manuela G Neuman, et al.
Izdano: (2016-01-01)

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
od: Gregory Habig, et al.
Izdano: (2021-04-01)

Incidental finding of non-alcoholic steatohepatitis-cirrhosis
od: Therese Adrian, et al.
Izdano: (2022-01-01)

Conophylline inhibits non-alcoholic steatohepatitis in mice.
od: Yukiomi Nakade, et al.
Izdano: (2017-01-01)

Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
od: Rafael S. Rios, et al.
Izdano: (2021-12-01)

Progress on cholesterol metabolism and non-alcoholic steatohepatitis
od: LI Xiao-xiao, SHU Xiang-bing, ZHANG Li
Izdano: (2022-07-01)

FEATURES OF THE COURSE OF RHEUMATOID ARTHRITIS IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS.
od: S. I. Smiian, et al.
Izdano: (2017-04-01)

Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma
od: Rahul Kumar, et al.
Izdano: (2020-04-01)

Non-Alcoholic Steatohepatitis Patient Characterization and Real-World Management Approaches in Italy
od: Bugianesi E, et al.
Izdano: (2024-10-01)

The effects of liraglutide on liver enzymes and metabolic factors in patients with nonalcoholic steatohepatitis: a meta-analysis of randomized controlled trials
od: Adnan Malik, et al.
Izdano: (2022-01-01)

Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
od: Sachiko Hattori, et al.
Izdano: (2021-03-01)

Non-Alcoholic Steatohepatitis in Myotonic Dystrophy: DMPK Gene Mutation, Insulin Resistance and Development of Steatohepatitis
od: Rishi R. Bhardwaj, et al.
Izdano: (2010-03-01)

COMPLEX HYPOLIPIDEMIC THERAPY OF PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS AND FAMILIAL HYPERCHOLESTEREMIA
od: Yakimenko O. O., et al.
Izdano: (2019-04-01)

A preliminary study of inflammatory markers in non-alcoholic steatohepatitis patients
od: Manopriya T. Priya, et al.
Izdano: (2010-03-01)

Сomparative Study of Progepar Efficacy in Patients with Non-Alcoholic Steatohepatitis
od: V.G. Perederii, et al.
Izdano: (2015-11-01)

Clinical Management of Non-alcoholic Steatohepatitis and the Role of the Cardiologist
od: Carlos Millán-Rodríguez, et al.
Izdano: (2023-12-01)

Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
od: Yu Junjie, et al.
Izdano: (2023-01-01)

Non-alcoholic Steatohepatitis: Global Impact and Clinical Consequences
od: Zobair Younossi, et al.
Izdano: (2022-03-01)

Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
od: Daryl Ramai, et al.
Izdano: (2021-02-01)

Non-alcoholic steatohepatitis in pregnancy: a case report
od: Jonathan Cordivani, et al.
Izdano: (2023-09-01)

Current, emerging, and potential therapies for non-alcoholic steatohepatitis
od: Zhen Yang, et al.
Izdano: (2023-03-01)

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
od: Kuei-Chuan Lee, et al.
Izdano: (2023-01-01)

REVIEW PAPER<br>Non-alcoholic steatohepatitis (NASH)
od: János Fehér, et al.
Izdano: (2005-04-01)